NEW ORLEANS — Patients with malignant glaucoma, or aqueous misdirection, who received surgical management were more likely to have better visual outcomes, according to a speaker at the American Academy of Ophthalmology meeting.
“The low incidence of malignant glaucoma makes it challenging to study,” Stephanie L. Cote, MD, said during a prerecorded presentation. “Most of the current literature is from case reports or small case series, and they are typically focused on a specific treatment option. Large-scale predictive studies or randomized trials have not been done.”